UK

AZ to continue with investment freeze following ‘no deal’ Brexit
AZ to continue with investment freeze following ‘no deal’ Brexit
Pharmaforum
AstraZeneca
drug manufacturing
Brexit
UK
Flag link:
UK clinical trials fall as Brexit clouds drug approval process
UK clinical trials fall as Brexit clouds drug approval process
Reuters
UK
Brexit
clinical trials
Flag link:
NHS, Gilead reach agreement for Yescarta
NHS, Gilead reach agreement for Yescarta
BioCentury
Yescarta
Gilead Sciences
UK
NHS
CAR-T
Flag link:
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Pharmaceutical Business Review
Alnylam
RNAi
ALN-AAT02
MHRA
UK
Flag link:
UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development
UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development
Endpoints
Brexit
UK
clinical trials
Recardio
Flag link:
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
UK
Roche
Avastin
wet age-related macular degeneration
Novartis
Bayer
Flag link:
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
Yahoo/Reuters
UK
Brexit
AstraZeneca
Pascal Soriot
drug shortages
Flag link:
NICE rejects Novartis’ CAR-T in adult lymphoma
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
NICE
UK
Novartis
CAR-T
Kymriah
NHS
diffuse large B-cell lymphoma
Flag link:
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Pharmaforum
Novo Nordisk
insulin
UK
Brexit
Flag link:
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
Pharmaforum
Brexit
Roche
Severin Schwan
UK
Flag link:
MS Society protests NICE rejection of Ocrevus for primary progressive MS
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
Flag link:
Novartis CAR-T therapy snags UK coverage, cutting list price 23% from US
Novartis CAR-T therapy snags UK coverage, cutting list price 23% from US
Biopharma Dive
Novartis
Kymriah
CAR-T
UK
Flag link:
UK’s drug supply contingency plan for hard Brexit
UK’s drug supply contingency plan for hard Brexit
Pharmaforum
UK
Europe
Brexit
Flag link:
UK rejects Gilead's CAR-T cancer cell therapy as too expensive
UK rejects Gilead's CAR-T cancer cell therapy as too expensive
Reuters
Yescarta
UK
Europe
CAR-T
NICE
Gilead Sciences
Flag link:
No-deal Brexit airlift? Sanofi may have to fly flu shots into the U.K. for the 2019-20 season
No-deal Brexit airlift? Sanofi may have to fly flu shots into the U.K. for the 2019-20 season
Fierce Pharma
Sanofi
vaccines
UK
Brexit
flu vaccines
Flag link:
Biogen's Spinraza gets an early no-go from NICE
Biogen's Spinraza gets an early no-go from NICE
Biopharma Dive
Biogen
UK
NICE
Spinraza
SMA
spinal muscular atrophy
Flag link:
The UK's MHRA Grants Early Access to Anlylam's Patisiran
The UK's MHRA Grants Early Access to Anlylam's Patisiran
CP Wire
Alnylam
Patisiran
hATTR amyloidosis
UK
Flag link:
U.K. to offer Merck's Gardasil to boys after years of protests
U.K. to offer Merck's Gardasil to boys after years of protests
Fierce Pharma
UK
Merck
Gardasil
HPV
vaccines
Flag link:
AstraZeneca to stockpile drugs as Brexit 'safety net'
AstraZeneca to stockpile drugs as Brexit 'safety net'
Reuters
AstraZeneca
Brexit
UK
Europe
Flag link:
Vertex spars with UK's May over Orkambi pricing
Vertex spars with UK's May over Orkambi pricing
Biopharma Dive
Vertex Pharmaceuticals
UK
cystic fibrosis
innovation
drug pricing
Orkambi
Flag link:

Pages